Diploma (LON:DPLM) Price Target Raised to GBX 6,600 at Royal Bank Of Canada

Diploma (LON:DPLM) had its target price lifted by Royal Bank Of Canada from GBX 6,200 to GBX 6,600 in a report issued on Thursday morning, Marketbeat.com reports. The brokerage currently has an outperform rating on the stock.

Other equities research analysts also recently issued reports about the stock. Peel Hunt reaffirmed a “buy” rating and set a GBX 6,150 price objective on shares of Diploma in a report on Friday, December 19th. Shore Capital Group reiterated a “hold” rating on shares of Diploma in a research note on Wednesday. Stifel Nicolaus boosted their price target on shares of Diploma from GBX 6,200 to GBX 6,800 and gave the company a “buy” rating in a research report on Thursday. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 6,350 price objective on shares of Diploma in a report on Wednesday, November 19th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Diploma from GBX 6,000 to GBX 6,200 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Five research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 6,023.75.

Diploma Trading Down 2.2%

Shares of DPLM opened at GBX 5,795 on Thursday. The business has a 50-day moving average of GBX 5,456.45 and a 200 day moving average of GBX 5,423.86. Diploma has a fifty-two week low of GBX 3,532 and a fifty-two week high of GBX 6,019.52. The firm has a market cap of £7.77 billion, a P/E ratio of 42.21, a price-to-earnings-growth ratio of 2.82 and a beta of 1.03. The company has a debt-to-equity ratio of 46.97, a quick ratio of 0.80 and a current ratio of 2.04.

Insiders Place Their Bets

In other Diploma news, insider Johnny Thomson sold 30,000 shares of Diploma stock in a transaction dated Friday, January 16th. The stock was sold at an average price of GBX 5,668, for a total transaction of £1,700,400. Also, insider Katie Bickerstaffe bought 352 shares of Diploma stock in a transaction on Wednesday, January 14th. The shares were bought at an average cost of GBX 5,645 per share, with a total value of £19,870.40. 1.14% of the stock is owned by corporate insiders.

Key Headlines Impacting Diploma

Here are the key news stories impacting Diploma this week:

• Positive Sentiment: Diploma upgraded full‑year guidance after a stronger‑than‑expected first half, citing resilient aerospace demand — this is the catalyst that drove the recent rally. Article Title Article Title
• Positive Sentiment: Berenberg raised its price target to GBX 7,500 and moved to a “buy” rating, signaling stronger analyst conviction. Article Title
• Positive Sentiment: Stifel Nicolaus lifted its target to GBX 6,800 and reiterated a “buy” stance, reflecting upgraded earnings assumptions. Article Title
• Positive Sentiment: RBC increased its target to GBX 6,600 and moved to “outperform” after Diploma’s guidance upgrade; coverage note posted to LSE and TickerReport. Article Title Article Title
• Positive Sentiment: Deutsche Bank raised its target to GBX 6,400 and set a “buy” rating, further supporting the upgraded consensus view. Article Title
• Neutral Sentiment: Shore Capital reaffirmed a “hold” rating — a reminder some brokers remain cautious despite upgrades. Article Title Article Title
• Neutral Sentiment: Valuation sits elevated after the rally (P/E ~42, PEG ~2.8) and the stock is near its 1‑year high — this raises the bar for further upside absent continued operational beats.
• Negative Sentiment: Despite the positive fundamentals and multiple target lifts, the stock is pulling back mid‑day on very heavy volume — likely short‑term profit‑taking and consolidation after the recent surge.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.